SYNTHESIS OF 4-(2-HYDROXYPHENYL)-5,6,7,8-TETRAHYDROISOXAZOLO [5,4-B]CHROMENE-5(4H)-ONES
Abstract
The aim of this work is the synthesis of new tetraheterocyclic compounds of interest as potential biologically active substances that include the isoxazole and chromone moieties in their structure. The synthesis of such compounds was carried out with two stages. By Knoevenagel condensation of 3-methyl-1,2-isoxazol-5(2H)-on with salicylic aldehyde (4Z)-4-(2-hydro-xybenzyliden)-3-methyl-1,2-oxazol-5(4H)-on was obtained. In this reaction an excess of half of the aldehyde equivalent was used to increase the yield of the product. Pyperidine was used as a catalyst. The reaction was carried out by boiling the components in ethyl acetate. The reaction of the resulting benzylidenisoxazole derivative with cyclohexane-1,3-dione or dimedone was performed by boiling the components in ethanol without the use of a catalyst. The interaction mechanism includes heterodiene Dielsa-Aldera condensation followed by dehydration of one water molecule. As a result, 3-methyl-4-(2-hydroxyphenyl-5,6,7,8-tetrahydroisoxazolo[5,4-b]chromene-5(4H)-one and 3,7,7-trimethyl-4-(2-hydroxyphenyl)-5,6,7,8,9-tetrahydroisoxazolo[5,4-b]chromen-5(4H)–one were obtained. Purification of the synthesized compounds was carried out by crystallization from ethanol. All the obtained compounds were characterised by IR 1H NMR and UV spectroscopies. In 1H NMR spectra there are signals of the methyl groups of the isoxazole ring of compounds at 2.26, 2.29, 2.34 ppm respectively. In the UV spectrum of a plane molecule of (4Z)-4-(2-hydroxybenzyliden)-3-methyl-1,2-oxazol-5(4H)-on there is a long-wave absorption maximum (400.9 nm) corresponding to the joint system of conjugated bonds of the isoxazole and aromatic rings. The structures of the obtained compounds were confirmed by high resolution mass-spectrometry analysis. In the spectra of 3-methyl-4-(2-hydroxyphenyl-5,6,7,8-tetrahydroisoxazolo[5,4-b]chromene-5(4H)-one and 3,7,7-trimethyl-4-(2-hydroxyphenyl)-5,6,7,8,9-tetrahydroisoxazolo[5,4-b]chromen-5(4H)–one the[M + Na]+ ion peaks were observed. The presence of fragment peaks [M + Na – CO]+ and [M + Na – CO – H2O]+ confirms the presence of hydroxy and carbonyl groups in the molecules.
References
Masters K.S., Bräse S. Xanthones from Fungi, Lichens, and Bacteria: The Natural Products and Their Synthesis. Chem. Rev. 2012. V. 112. N 7. P. 3717–3776. DOI: 10.1021/cr100446h.
Elinson M.N., Nasybullin R.F., Sokolova O.O., Zai-movskaya T.A., Egorov M.P. Non-catalytic multicomponent rapid and efficient approach to 10-(2,4,6-trioxohexahydropyrimidin-5-yl)-3,3-dimethyl-2,3,4,9-tetrahydro-1H-xanthen-1-ones from salicylaldehydes, dim-edone, and barbituric acids. Monatsh Chem. 2015. V. 146. N 10. P. 1689–1694. DOI: 10.1007/s00706-015-1512-x.
Wang H.J., Ren X.Q., Zhang Y.Y., Zhang Z.H. Synthesis 12-Aryl or 12-Alkyl-8,9,10,12-tetrahydrobenzo[a]xanthen-11-one derivatives catalyzed by dodecatungstophosphoric ac-id. J. Braz. Chem. Soc. 2009. V. 20. N 10. P. 1939-1943. DOI: 10.1590/S0103-50532009001000025.
Woo S., Jung J., Lee C., Kwon Y., Na Y. Synthesis of new xanthone analogues and their biological activity test—Cytotoxicity, topoisomerase II inhibition, and DNA cross-linking study. Bioorg. Med. Chem. Lett. 2007. V. 17. P. 1163-1169. DOI: 10.1016/ j.bmcl.2006.12.030.
Giri R., Goodell J.R., Xing C., Benoit A., Kaur H., Hiasa H., Ferguson D.M. Synthesis and cancer cell cytotoxicity of substituted xanthenes. Bioorg. Med. Chem. 2010. V. 18. N 4. P. 1456-1463. DOI: 10.1016/j.bmc.2010.01.018.
Kafle B., Cho H. Isoxazolone derivatives as potent inhibitors of PTP1B. Bull. Korean Chem. Soc. 2012. V. 33. P. 275–277. DOI: 10.5012/bkcs.2012.33.1.275.
Conti P., Tamborini L., Pinto A., Sola L., Ettari R., Mer-curio C., De Micheli C. Design and synthesis of novel isoxa-zole-based HDAC inhibitors. Eur. J. Med. Chem. 2010. V. 45. P. 4331–4338. DOI: 10.1016/j.ejmech.2010.06.035.
Changtam C., Hongmanee P., Suksamrarn A. Isoxazole analogs of curcuminoids with highly potent multidrug-resistant antimycobacterial activity. Eur. J. Med. Chem. 2010. V. 45. N 10. P. 4446-4457. DOI: 10.1016/j.ejmech.2010.07.003.
Karabasanagouda T., Adhikari A.V., Girisha M. Synthe-sis of some new pyrazolines and isoxazoles carrying 4-methylthiophenyl moiety as potential analgesic and anti-inflammatory agents. Indian J. Chem. 2009. V. 48B. N 3.
P. 430-437. http://nopr.niscair.res.in/handle/123456789/ /3473.
Kamal A., Bharathi E.V., Reddy J.S., Janaki M., Ramaiah D., Reddy M.K., Viswanath A., Reddy T.L., Shaik T.B., Pushpavalli S.N., Bhadra M.P. Synthesis and biological evaluation of 3,5-diaryl isoxazoline/isoxazole linked 2,3-dihydro-quinazolinone hybrids as anticancer agents. Eur. J. Med. Chem. 2011. V. 46. N 2. P. 691-703. DOI: 10.1016/ j.ejmech.2010.12.004.
Mao J., Yuan H., Wang Y., Wan B., Pak D., He R., Franzblau S.G. Synthesis and antituberculosis activity of novel mefloquine-isoxazole carboxylic esters as prodrugs. Bioorg. Med. Chem. Lett. 2010. V. 20. N 3. P. 1263-1268. DOI: 10.1016/j.bmcl.2009.11.105.
Padmaja A., Rajasekhar C., Muralikrishna A., Padmavathi V. Synthesis and antioxidant activity of oxazol-yl/thiazolylsulfonylmethyl pyrazoles and isoxazoles. Eur. J. Med. Chem. 2011. V. 46. N 10. P. 5034-5038. DOI: 10.1016/j.ejmech.2011.08.010.
Kiyani. H., Ghorbani F. Potassium phthalimide as efficient basic organocatalyst for the synthesis of 3,4-disubstituted isoxazol-5(4H)-ones in aqueous medium. J. Saudi Chem. Soc. 2017. V. 21. N 1. P. 112-119. DOI: 10.1016/j.jscs.2013.11.002.
Shirini F., Abedini M., Pourhasan R. N-Sulfonic Acid Poly(4-Vinylpyridinium) Chloride: A Novel Polymeric and Reusable Catalyst for the Preparation of Xanthenes Deriva-tives. Dyes and Pigments. 2013. V. 99 N 1. P. 250-255. DOI: 10.1016/j.dyepig.2013.04.036.
dos Santos W.H., Silva-Filho L.C.D. Facile and efficient synthesis of xanthenedione derivatives promoted by niobium pentachloride. Chem. Papers. 2016. V. 70. N 12. P. 1658–1664. DOI: 10.1515/chempap-2016-0098.
Makone S., Mahurkar Sh. A Green Protocol for Efficient Synthesis of 1,8-Dioxo-Octahydroxanthenes Using Ionic Liquid. Green and Sustainable Chem. 2013. V. 3. N 4A. P. 27-32. DOI: 10.4236/gsc.2013.34A005.
Pyrko A.N. Synthesis of tetra- and octahydroxanthene deriva-tives by the condensation of dimedone with aromatic alde-hydes. Chem. Heterocycl. Compd. 1996. V. 32. N 6. P. 635-645. DOI: 10.1007/BF01164861.
Kasralikar H.M., Jadhavar S.C., Bhusare S.R. Synthesis and molecular docking studies of oxochromenyl xanthenone and indolyl xanthenone derivatives as anti-HIV-1 RT inhibi-tors. Bioorg. Med. Chem. Lett. 2015. V. 25. N 18. P. 3882-3886. DOI: 10.1016/j.bmcl.2015.07.050.
Cheng Q., Xu X., Liua L., Zhanga L. 4-(2-Hydroxybenzy-lidene)-3-methylizoxazol-5(4H)-one. Crystallograph. Com-mun. 2009. V. 65. N 12. P. 3012. DOI: 10.1107/S1600536809045486.
Ozols Ya.Ya., Pyrko A.N., Lakhvich F.A., Vigante B.A., Dubure R.R., Dubur, G.Ya., Akhrem A.A. Synthesis of Decahydrophenanthridine-1,7-dione and Hexahydroisoquinol-8-one Derivatives in the Deaction of 2-acetyl-2-cyclohexene-1-ones with Conjugated Enaminocarbonyl Compounds. Chem. Heterocycl. Compd. 1990. V. 26. N 1. P. 58-62. DOI: 10.1007/BF00506849.
Palasz A., Ciez D., Musielak B., Kalinowska – Tluscik J. Application of dimedone enamines as dienophiles: stereoselec-tive synthesis of amino enols of fused uracils containing a sugar moiety by hetero-Diels–Alder reactions of barbituric ac-id 5-ylidene alditols with dimedone enamines. Tetrahedron. 2015. V. 71. N 47. P. 8911-8924. DOI: 10.1016/j.tet.2015.09.065.
Schmidt R.R., Maier M. Hetero-diels-alder reactions of α-methoxymethylene substituted 1.3-dicarbonyl compounds with enol and enediol ethers. Tetrahedron Lett. 1982. V. 23. N 17. P. 1789-1792. DOI: 10.1016/S0040-4039(00)86742-8.
